US Bancorp’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

US Bancorp’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,081	Closed	-$360K	–	3752
2015 Q1	$360K	Sell	2,081 -754	-27%	-$111K	﹤0.01%	1521
2014 Q4	$326K	Sell	2,835 -5,078	-64%	-$615K	﹤0.01%	1557
2014 Q3	$1.24M	Sell	7,913 -1,944	-20%	-$282K	0.01%	893
2014 Q2	$1.22M	Buy	9,857 +116	+1%	+$12.8K	﹤0.01%	907
2014 Q1	$1.01M	Buy	9,741 +3,030	+45%	+$310K	﹤0.01%	976
2013 Q4	$604K	Sell	6,711 -407	-6%	-$32.5K	﹤0.01%	1204
2013 Q3	$476K	Buy	7,118 +2,539	+55%	+$175K	﹤0.01%	1264
2013 Q2	$303K	Buy	+4,579	New	+$262K	﹤0.01%	1434

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

US Bancorp's SLXP Position: Q2 2015 in Review

US Bancorp sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 2,081 shares — an estimated $360K sold.

US Bancorp first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $1.24M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

US Bancorp reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
US Bancorp sold 2,081 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $360K.
US Bancorp first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
US Bancorp's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.24M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on US Bancorp's 13F filing for Q2 2015, filed 10 Aug 2015.